Jazz Return On Assets from 2010 to 2024

JAZZ Stock  USD 123.60  2.88  2.39%   
Jazz Pharmaceuticals Return On Assets yearly trend continues to be fairly stable with very little volatility. Return On Assets are likely to outpace its year average in 2024. Return On Assets is a profitability ratio that indicates the percentage of profit Jazz Pharmaceuticals PLC earns in relation to its overall resources. It is calculated by dividing net income by total assets. View All Fundamentals
 
Return On Assets  
First Reported
2010-12-31
Previous Quarter
0.03640998
Current Value
0.0382
Quarterly Volatility
0.19819577
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 303.9 M, Other Operating Expenses of 3.4 B or Operating Income of 607.5 M, as well as many indicators such as Price To Sales Ratio of 1.93, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Return On Assets Growth Pattern

Below is the plot of the Return On Assets of Jazz Pharmaceuticals PLC over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Jazz Pharmaceuticals' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Very volatile
   Return On Assets   
       Timeline  

Jazz Return On Assets Regression Statistics

Arithmetic Mean0.05
Coefficient Of Variation392.22
Mean Deviation0.11
Median0.08
Standard Deviation0.20
Sample Variance0.04
Range1.0097
R-Value(0.01)
Mean Square Error0.04
R-Squared0.0001
Significance0.97
Slope(0.0005)
Total Sum of Squares0.55

Jazz Return On Assets History

2024 0.0382
2023 0.0364
2022 -0.0198
2021 -0.0267
2020 0.0365
2019 0.0945
2018 0.0859

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Return On Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Assets 0.04  0.04 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.